Bioscience Animal Health Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Dhanawat Khongjaroensombat

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	8.9%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Geschäftsführer

Dhanawat Khongjaroensombat

no data

Amtszeit

Mr. Dhanawat Khongjaroensombat is Chief Executive Officer & Director of Bio Science Animal Health Public Company Limited.

Bioscience Animal Health Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Insufficient new directors

Bioscience Animal Health Public Company Limited Announces Changing of Chief Accountant

Recent updates

Investor sentiment improves as stock rises 15%

Bioscience Animal Health Public Company Limited Announces Cash Dividend for the Operating Period from January 1, 2024 to June 30, 2024, Payable on September 11, 2024

First half dividend increased to ฿0.05

Second quarter 2024 earnings released: EPS: ฿0.051 (vs ฿0.038 in 2Q 2023)

Investor sentiment improves as stock rises 16%

First quarter 2024 earnings released: EPS: ฿0.043 (vs ฿0.02 in 1Q 2023)

Bioscience Animal Health Public Company Limited Approves the Remaining Dividend Payment from the Second Half Six-Month Operating Period 2023, Payable on May 21, 2024

Upcoming dividend of ฿0.07 per share

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Full year 2023 earnings released: EPS: ฿0.16 (vs ฿0.20 in FY 2022)

Final dividend increased to ฿0.07

Bioscience Animal Health Public Company Limited, Annual General Meeting, Apr 24, 2024

Insufficient new directors

Bioscience Animal Health Public Company Limited Announces Changing of Chief Accountant

New minor risk - Share price stability

Upcoming dividend of ฿0.04 per share at 1.9% yield

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: ฿0.038 (vs ฿0.042 in 2Q 2022)

Bioscience Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2023 to June 30, 2023, Payable on September 08, 2023

First quarter 2023 earnings released: EPS: ฿0.02 (vs ฿0.079 in 1Q 2022)

Upcoming dividend of ฿0.063 per share at 2.0% yield

Third quarter 2022 earnings released: EPS: ฿0.04 (vs ฿0.09 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: ฿0.04 (vs ฿0.09 in 2Q 2021)

Bio Science Animal Health Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022, Payable on September 09, 2022

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Bio Science Animal Health Public Company Limited has completed an IPO in the amount of THB 564 million.

Full year 2021 earnings released

Geschäftsführer

Amtszeit